Composition of cross-functional team for emerging threat relating to anomalous health incidents; reports

(a) Team composition Subsection (c) of section 910 of the National Defense Authorization Act for Fiscal Year 2022 (Public Law 117–81; 10 U.S.C. 111 note) is amended— (1) in the subsection heading, by inserting and composition after leadership; (2) by striking The Secretary and inserting the following: (1) Leadership The Secretary; and (3) by adding at the end the following new paragraph: (2) Composition At a minimum, the cross-functional team shall be staffed by at least one full-time employee designated by each of the following: (A) The Under Secretary of Defense for Policy. (B) The Under Secretary of Defense for Personnel and Readiness. (C) The Under Secretary of Defense for Intelligence and Security. (D) The Under Secretary of Defense for Research and Engineering. (E) The Director of the Defense Intelligence Agency. (F) The Director of the Defense Health Agency. (G) The Director of the National Security Agency.. (b) Quarterly reports Subsection (e) of such section is amended— (1) in the subsection heading, by inserting and reports after Briefings; and (2) by striking paragraph (2) and inserting the following new paragraph (2): (2) Quarterly reports Not later than 90 days after the date of the enactment of the National Defense Authorization Act for Fiscal Year 2027, and every 90 days thereafter until March 1, 2030, the head of the cross-functional team shall submit to the appropriate congressional committees a report that includes the following: (A) A description of any activities carried out to fulfill the duties specified in subsection (b) during the 90-day period preceding submission of the report. (B) A description of any organizational updates to the team, including the status of employees assigned to the team under subsection (c)(2). (C) The number of anomalous health incidents reported during the 90-day period preceding submission of the report, and the date and location of each such incident. (D) An assessment of the status of funding, by fiscal year, for research described in subsection (b)(2) and a description of the topics covered by such research..